Varkey Dax T, Patterson Brendan M, Creighton R Alexander, Spang Jeffrey T, Kamath Ganesh V
Department of Orthopaedic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Department of Orthopaedic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
J Shoulder Elbow Surg. 2016 Dec;25(12):e378-e385. doi: 10.1016/j.jse.2016.05.001. Epub 2016 Aug 2.
Rotator cuff tears have a lifetime incidence between 25% and 40% in the United States, but optimum treatment strategies and protocol have not yet been widely accepted. This study evaluated the proportions of patients treated with nonoperative and operative modalities and how this proportion has changed during an 8-year period (2005-2012) among patients with Medicare.
Using the PearlDiver patient record database, we identified Medicare patients having been diagnosed with a rotator cuff tear. These patients were then stratified on the basis of treatment with physical therapy, subacromial/glenohumeral injection, or rotator cuff repair. We analyzed the data in regard to standard demographic information, comorbidities, and the Charlson Comorbidity Index.
During the study period, 878,049 patients were identified and 397,116 patients had rotator cuff repair. The proportion of patients treated initially with physical therapy dropped from 30.0% in 2005 to 13.2% in 2012, and the subacromial/glenohumeral injection proportion decreased from 6.00% to 4.19% (P < .001). The proportion of patients who had rotator cuff repair increased from 33.8% to 40.4% from 2005 to 2012 (P < .001). Charlson Comorbidity Indexes were significantly lower in operative patients compared with each nonoperative treatment examined.
This analysis demonstrates a significant decrease in the initial trial of nonoperative treatment and an increase in the rate of surgery. Patients undergoing rotator cuff repair had fewer comorbidities than those undergoing nonoperative treatments. It also demonstrates that patients who had a trial of injection had a higher incidence of eventual rotator cuff repair compared with the patients with an initial trial of physical therapy.
在美国,肩袖撕裂的终生发病率在25%至40%之间,但最佳治疗策略和方案尚未被广泛接受。本研究评估了接受非手术和手术治疗方式的患者比例,以及在8年期间(2005 - 2012年)医疗保险患者中这一比例是如何变化的。
使用PearlDiver患者记录数据库,我们识别出被诊断为肩袖撕裂的医疗保险患者。然后根据物理治疗、肩峰下/盂肱关节注射或肩袖修复治疗对这些患者进行分层。我们分析了有关标准人口统计学信息、合并症和查尔森合并症指数的数据。
在研究期间,共识别出878,049例患者,其中397,116例患者接受了肩袖修复。最初接受物理治疗的患者比例从2005年的30.0%降至2012年的13.2%,肩峰下/盂肱关节注射比例从6.00%降至4.19%(P <.001)。从2005年到2012年,接受肩袖修复的患者比例从33.8%增加到40.4%(P <.001)。与每种非手术治疗相比,手术患者的查尔森合并症指数显著更低。
该分析表明非手术治疗的初始试验显著减少,手术率增加。接受肩袖修复的患者比接受非手术治疗的患者合并症更少。它还表明,与最初接受物理治疗的患者相比,接受注射试验的患者最终进行肩袖修复的发生率更高。